News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,765 Results
Type
Article (50433)
Company Profile (329)
Press Release (709991)
Multimedia
Podcasts (116)
Webinars (20)
Section
Business (212054)
Career Advice (2129)
Deals (36575)
Drug Delivery (131)
Drug Development (83444)
Employer Resources (177)
FDA (17114)
Job Trends (15759)
News (359113)
Policy (35175)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2845)
Academic (2)
Accelerated approval (33)
Adcomms (28)
Allergies (148)
Alliances (51751)
ALS (172)
Alzheimer's disease (1737)
Antibody-drug conjugate (ADC) (323)
Approvals (17367)
Artificial intelligence (558)
Autoimmune disease (159)
Automation (39)
Bankruptcy (369)
Best Places to Work (12258)
BIOSECURE Act (21)
Biosimilars (199)
Biotechnology (201)
Bladder cancer (157)
Brain cancer (59)
Breast cancer (652)
Cancer (4906)
Cardiovascular disease (415)
Career advice (1806)
Career pathing (38)
CAR-T (289)
CDC (56)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (37)
Clinical research (71084)
Collaboration (1784)
Company closure (4)
Compensation (1166)
Complete response letters (58)
COVID-19 (2902)
CRISPR (98)
C-suite (883)
Cystic fibrosis (148)
Data (6295)
Decentralized trials (2)
Denatured (38)
Depression (140)
Diabetes (518)
Diagnostics (7048)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (262)
Drug pricing (208)
Drug shortages (29)
Duchenne muscular dystrophy (238)
Earnings (91869)
Editorial (64)
Employer branding (22)
Employer resources (155)
Events (125964)
Executive appointments (1023)
FDA (20304)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1543)
Gene editing (211)
Generative AI (52)
Gene therapy (624)
GLP-1 (1030)
Government (5246)
Grass and pollen (7)
Guidances (384)
Healthcare (20369)
HIV (61)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (261)
Immuno-oncology (58)
Indications (110)
Infectious disease (3195)
Inflammatory bowel disease (195)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (252)
Interviews (335)
IPO (16981)
IRA (54)
Job creations (3863)
Job search strategy (1510)
JPM (67)
Kidney cancer (16)
Labor market (87)
Layoffs (574)
Leadership (32)
Legal (8510)
Liver cancer (96)
Longevity (15)
Lung cancer (655)
Lymphoma (378)
Machine learning (43)
Management (61)
Manufacturing (814)
MASH (171)
Medical device (14431)
Medtech (14487)
Mergers & acquisitions (20682)
Metabolic disorders (1326)
Multiple sclerosis (163)
NASH (17)
Neurodegenerative disease (335)
Neuropsychiatric disorders (94)
Neuroscience (3005)
Neurotech (1)
NextGen: Class of 2026 (7127)
Non-profit (4948)
Now hiring (67)
Obesity (631)
Opinion (289)
Ovarian cancer (168)
Pain (206)
Pancreatic cancer (234)
Parkinson's disease (289)
Partnered (34)
Patents (502)
Patient recruitment (499)
Peanut (57)
People (61493)
Pharmaceutical (74)
Pharmacy benefit managers (32)
Phase 1 (22232)
Phase 2 (31134)
Phase 3 (23231)
Pipeline (5346)
Policy (314)
Postmarket research (2762)
Preclinical (9426)
Press Release (71)
Prostate cancer (244)
Psychedelics (53)
Radiopharmaceuticals (291)
Rare diseases (876)
Real estate (6242)
Recruiting (71)
Regulatory (25987)
Reports (53)
Research institute (2600)
Resumes & cover letters (364)
Rett syndrome (27)
RNA editing (16)
RSV (83)
Schizophrenia (152)
Series A (256)
Series B (200)
Service/supplier (13)
Sickle cell disease (103)
Special edition (24)
Spinal muscular atrophy (163)
Sponsored (45)
Startups (3842)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (89)
The Weekly (76)
Vaccines (1111)
Venture capital (94)
Weight loss (412)
Women's health (95)
Worklife (19)
Date
Today (30)
Last 7 days (606)
Last 30 days (2099)
Last 365 days (30873)
2026 (3602)
2025 (31281)
2024 (36405)
2023 (41346)
2022 (52603)
2021 (57322)
2020 (56298)
2019 (49436)
2018 (37429)
2017 (33560)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (858)
Alabama (88)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (41984)
Australia (6973)
California (11527)
Canada (3326)
China (1135)
Colorado (489)
Connecticut (501)
Delaware (341)
Europe (91863)
Florida (1713)
Georgia (372)
Hawaii (4)
Idaho (67)
Illinois (914)
India (67)
Indiana (535)
Iowa (23)
Japan (440)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (83)
Maryland (1436)
Massachusetts (8344)
Michigan (350)
Minnesota (657)
Mississippi (5)
Missouri (133)
Montana (34)
Nebraska (28)
Nevada (126)
New Hampshire (84)
New Jersey (3098)
New Mexico (29)
New York (3050)
North Carolina (1545)
North Dakota (9)
Northern California (5598)
Ohio (352)
Oklahoma (22)
Oregon (43)
Pennsylvania (2308)
Puerto Rico (24)
Rhode Island (48)
South America (1225)
South Carolina (68)
South Dakota (1)
Southern California (4502)
Tennessee (176)
Texas (1793)
United States (41235)
Utah (345)
Vermont (1)
Virginia (274)
Washington D.C. (84)
Washington State (949)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
760,765 Results for "lucira health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call
January 13, 2026
·
1 min read
Press Releases
Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call
January 27, 2026
·
2 min read
Press Releases
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 29, 2026
·
1 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community
January 6, 2026
·
5 min read
Press Releases
Optimi Health Announces Equity Incentive Grants and Corporate Update
January 16, 2026
·
4 min read
Biotech Bay
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
Lucira Health, Inc. announced the launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the $29 price of the test, excluding prescription costs.
November 17, 2022
·
5 min read
Biotech Bay
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
Lucira Health, Inc. announced the Canadian launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the price of the test, excluding prescription costs.
January 4, 2023
·
6 min read
Business
Lucira Health to Announce Third Quarter 2022 Financial Results
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, and a digital health platform that will connect patients with providers, today announced that the company will report third quarter 2022 financial results on, Monday, November 14th, 2022.
November 1, 2022
·
1 min read
1 of 76,077
Next
